Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
First Mining Announces Year-End 2022 Financial Results and Operating Highlights (click to learn more) Heritage Mining Announces up to $1,500,000 Non-Brokered PP of Units and FT Units (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc. CRL

Healthcare Diagnostics & Research
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including...


Recent & Breaking News (NYSE:CRL)

CRL LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

PR Newswire 14 hours ago

Charles River Shareholder Action Reminder

Newsfile 1 day ago

Charles River Shareholder Notice

Newsfile 6 days ago

Charles River Shareholder Action Reminder

Newsfile 8 days ago

Charles River Shareholder Notice

Newsfile 10 days ago

TOP RANKED ROSEN LAW FIRM Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

Newsfile 11 days ago

Charles River Investor Alert

Newsfile 12 days ago

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

PR Newswire 12 days ago

Charles River Shareholder Notice

Newsfile 13 days ago

Charles River Shareholder Action Reminder

Newsfile March 15, 2023

Charles River Investor Alert

Newsfile March 14, 2023

ROSEN, Top Ranked Investor Counsel, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

Newsfile March 14, 2023

Charles River Shareholder Notice

Newsfile March 13, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

PR Newswire March 13, 2023

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire March 13, 2023

Charles River Launches Apollo(TM), an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Business Wire March 13, 2023

Charles River Investor Alert

Newsfile March 12, 2023

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

PR Newswire March 11, 2023

Charles River Shareholder Action Reminder

Newsfile March 10, 2023

Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing

Business Wire March 9, 2023